Cost Transparency
Latest Releases
-
Prescription Drug Manufacturers
CTRx Reporting# Health and Safety Code §§ 12679 – 127681 define the types of prescription drug cost transparency reporting manufacturers...
-
Prescription Drug Cost Transparency Public ReportingView data on wholesale acquisition cost increases for prescription drugs.
-
The HCAI Update News Video for September is outIt's been a busy summer for HCAI, from conferences and releasing new data and reports, to completing construction financing deals....
-
New Quarter of Data Available for New Prescription DrugsView reported information on specified prescription drugs introduced to market in the first two quarters of 2019.
-
HPD Review Committee
The Healthcare Payments Data (HPD) Review Committee is comprised of healthcare stakeholders and experts to support the planning and development...
-
New Prescription Drug Manufacturer Notifications (Cost Transparency Rx)The online system is available for prescription drug manufacturers to submit new prescription drug cost information to HCAI.
-
Cost Transparency
Hospital and long-term financials, Chargemasters, prescription drug costs, and more to support and advance healthcare cost transparency.
-
Cost Transparency Healthcare Payments Data Program – Phase 1 Implementation Plan Now AvailableThe Phase 1 Implementation Plan for the Cost Transparency Healthcare Payments Data Program is now available.
-
Health Care Payments Data (HPD)
The 2018 Budget Act included a one-time appropriation for HCAI to develop and administer a statewide Healthcare Cost Transparency Database...
-
Office of Appeals and Hearings
Information about Notice of Penalty, Request for Administrative Hearing, and Request for Consolidation of Appeals.